Liminatus Pharma Deal History & Licensing Activity
Liminatus Pharma is a life sciences. Over the past three years, Liminatus Pharma has been involved in 1 licensing and acquisition transaction, with a primary focus on CAR-T (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
CAR-T
Focus Area
Mega Deals
Liminatus Pharma Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Liminatus Pharma in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| CAR-T oncology platform | InnocsAI | CAR-T | Unknown | acquisition | May 2026 |
Liminatus Pharma Pipeline Focus
Therapeutic areas and modalities where Liminatus Pharma is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Liminatus Pharma's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Mega Deals assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
CAR-T Benchmarks
Upfront, milestone, and royalty benchmarks for car-t deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Liminatus Pharma Licensing & Deal Activity
Liminatus Pharma is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Liminatus Pharma ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Liminatus Pharma include Mega Deals (2 deals and trials). In terms of modality, Liminatus Pharma has shown particular interest in car-t.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Liminatus Pharma and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Liminatus Pharma's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.